PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
05-Apr-2022 Quadram Scientists Demonstrate Advantages of Fire Monkey HMW-DNA Extraction with Multiplexed Oxford Nanopore DNA Sequencing for Complete Hybrid Assemblies of Pathogen Genomes RevoluGen
04-Apr-2022 PerkinElmer Introduces First Ready-to-use HTRF® and AlphaLISA® Assay Kits for CHO HCP Impurities Detection and Quantification PerkinElmer, Inc.
04-Apr-2022 Stanley Capital-backed portfolio company DSS acquires MyMeds&Me MyMeds&Me
04-Apr-2022 CardioRenal raises €3.3 million Andrew Lloyd Associates
31-Mar-2022 Solvay Brussels School of Economics and Management joins forces with the Belgian life sciences ecosystem to train the next generation of Biotech and MedTech leaders Solvay Brussels School of Economics and Management
30-Mar-2022 Tower Cold Chain launches KTEvolution container for pharmaceutical transport Tower Cold Chain
29-Mar-2022 CD Formulation Announces to Offer Nitrosamine Impurities Analysis Service for Drug Formulation Projects CD Formulation
29-Mar-2022 Carthera’s SonoCloud technology demonstrates safety and therapeutic potential in clinical trial on patients living with Alzheimer’s Disease Andrew Lloyd Associates
29-Mar-2022 Medtech start-up Ubiplug obtains ISO 13485:2016 certification Andrew Lloyd Associates
29-Mar-2022 Fc Fusion Protein Production Service Now Available at Profacgen Profacgen
28-Mar-2022 Catalytic Data Science Joins Integrated DNA Technologies Align Program Integrated DNA Technologies
28-Mar-2022 HCL Technologies Expands Global Partnership with Novo Nordisk HCL Technologies
28-Mar-2022 Seekyo adds diagnostics and theranostics capabilities to its lead compound SKY01 that targets solid tumors Andrew Lloyd Associates
28-Mar-2022 Creative Peptides Rolls Out PNA FISH Probes with High Sensitivity and Specific Hybridization Creative Peptides
25-Mar-2022 ICR welcomes FDA approval of ‘search and destroy’ treatment The Institute of Cancer Research
25-Mar-2022 Tiziana Announces Initiation of Phase 1b Clinical Trial in Crohn’s Disease Patients to Evaluate Oral Capsules of Foralumab, a Fully Human Anti-CD3 Monoclonal Antibody Tiziana Life Sciences Ltd
25-Mar-2022 XFret Wins the 2021 Sustainability Award – Startup/Small Business Category TIACA
25-Mar-2022 OncoArendi Therapeutics Reports Continued Strategic and Operational Momentum for 12 Months ended 31 December 2021 OncoArendi
25-Mar-2022 TIACA Announces the Take-Off of the BlueSky Program TIACA
25-Mar-2022 Jazz Pharmaceuticals Announces Significant New Investment in UK Manufacturing Jazz Pharmaceuticals